These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 28750194)

  • 1. Ketoacidosis alone does not predispose to mucormycosis by Lichtheimia in a murine pulmonary infection model.
    Schulze B; Rambach G; Schwartze VU; Voigt K; Schubert K; Speth C; Jacobsen ID
    Virulence; 2017 Nov; 8(8):1657-1667. PubMed ID: 28750194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative immunopathogenesis in a murine model of inhalative infection with the mucormycetes Lichtheimia corymbifera and Rhizopus arrhizus.
    Rambach G; Fleischer V; Harpf V; Lackner M; Meinitzer A; Maier H; Engesser J; Lass-Flörl C; Speth C
    PLoS One; 2020; 15(6):e0234063. PubMed ID: 32555589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First Case of Rhinocerebral Mucormycosis Caused by Lichtheimia ornata, with a Review of Lichtheimia Infections.
    Pan J; Tsui C; Li M; Xiao K; de Hoog GS; Verweij PE; Cao Y; Lu H; Jiang Y
    Mycopathologia; 2020 Jun; 185(3):555-567. PubMed ID: 32388712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lichtheimia species exhibit differences in virulence potential.
    Schwartze VU; Hoffmann K; Nyilasi I; Papp T; Vágvölgyi C; de Hoog S; Voigt K; Jacobsen ID
    PLoS One; 2012; 7(7):e40908. PubMed ID: 22911715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adaptation to thermotolerance in Rhizopus coincides with virulence as revealed by avian and invertebrate infection models, phylogeny, physiological and metabolic flexibility.
    Kaerger K; Schwartze VU; Dolatabadi S; Nyilasi I; Kovács SA; Binder U; Papp T; Hoog Sd; Jacobsen ID; Voigt K
    Virulence; 2015; 6(4):395-403. PubMed ID: 26065324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucormycoses caused by Lichtheimia species.
    Schwartze VU; Jacobsen ID
    Mycoses; 2014 Dec; 57 Suppl 3():73-8. PubMed ID: 25186921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mucormycosis--from the pathogens to the disease.
    Binder U; Maurer E; Lass-Flörl C
    Clin Microbiol Infect; 2014 Jun; 20 Suppl 6():60-6. PubMed ID: 24476149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased virulence of Cunninghamella bertholletiae in experimental pulmonary mucormycosis: correlation with circulating molecular biomarkers, sporangiospore germination and hyphal metabolism.
    Petraitis V; Petraitiene R; Antachopoulos C; Hughes JE; Cotton MP; Kasai M; Harrington S; Gamaletsou MN; Bacher JD; Kontoyiannis DP; Roilides E; Walsh TJ
    Med Mycol; 2013 Jan; 51(1):72-82. PubMed ID: 22686246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-CotH3 antibodies protect mice from mucormycosis by prevention of invasion and augmenting opsonophagocytosis.
    Gebremariam T; Alkhazraji S; Soliman SSM; Gu Y; Jeon HH; Zhang L; French SW; Stevens DA; Edwards JE; Filler SG; Uppuluri P; Ibrahim AS
    Sci Adv; 2019 Jun; 5(6):eaaw1327. PubMed ID: 31206021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CotH3 mediates fungal invasion of host cells during mucormycosis.
    Gebremariam T; Liu M; Luo G; Bruno V; Phan QT; Waring AJ; Edwards JE; Filler SG; Yeaman MR; Ibrahim AS
    J Clin Invest; 2014 Jan; 124(1):237-50. PubMed ID: 24355926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of EGFR Signaling Protects from Mucormycosis.
    Watkins TN; Gebremariam T; Swidergall M; Shetty AC; Graf KT; Alqarihi A; Alkhazraji S; Alsaadi AI; Edwards VL; Filler SG; Ibrahim AS; Bruno VM
    mBio; 2018 Aug; 9(4):. PubMed ID: 30108171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene expansion shapes genome architecture in the human pathogen Lichtheimia corymbifera: an evolutionary genomics analysis in the ancient terrestrial mucorales (Mucoromycotina).
    Schwartze VU; Winter S; Shelest E; Marcet-Houben M; Horn F; Wehner S; Linde J; Valiante V; Sammeth M; Riege K; Nowrousian M; Kaerger K; Jacobsen ID; Marz M; Brakhage AA; Gabaldón T; Böcker S; Voigt K
    PLoS Genet; 2014 Aug; 10(8):e1004496. PubMed ID: 25121733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Galleria mellonella as a model system to study virulence potential of mucormycetes and evaluation of antifungal treatment.
    Maurer E; Hörtnagl C; Lackner M; Grässle D; Naschberger V; Moser P; Segal E; Semis M; Lass-Flörl C; Binder U
    Med Mycol; 2019 Apr; 57(3):351-362. PubMed ID: 29924357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GRP78 and Integrins Play Different Roles in Host Cell Invasion during Mucormycosis.
    Alqarihi A; Gebremariam T; Gu Y; Swidergall M; Alkhazraji S; Soliman SSM; Bruno VM; Edwards JE; Filler SG; Uppuluri P; Ibrahim AS
    mBio; 2020 Jun; 11(3):. PubMed ID: 32487760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucormycosis in India: unique features.
    Chakrabarti A; Singh R
    Mycoses; 2014 Dec; 57 Suppl 3():85-90. PubMed ID: 25187095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lichtheimia hongkongensis sp. nov., a novel Lichtheimia spp. associated with rhinocerebral, gastrointestinal, and cutaneous mucormycosis.
    Woo PC; Lau SK; Ngan AH; Tung ET; Leung SY; To KK; Cheng VC; Yuen KY
    Diagn Microbiol Infect Dis; 2010 Mar; 66(3):274-84. PubMed ID: 20159375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corticosteroids alter alveolar macrophage control of Lichtheimia corymbifera spores in an ex vivo mouse model.
    Brunet K; Arrivé F; Martellosio JP; Lamarche I; Marchand S; Rammaert B
    Med Mycol; 2021 Jul; 59(7):694-700. PubMed ID: 33369666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The TLR-NF-kB axis contributes to the monocytic inflammatory response against a virulent strain of
    Montaño DE; Hartung S; Wich M; Ali R; Jungnickel B; von Lilienfeld-Toal M; Voigt K
    Front Immunol; 2022; 13():882921. PubMed ID: 36311802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case of COVID-19-associated mucormycosis due to Lichtheimia ramosa.
    Aboutalebian S; Erami M; Momen-Heravi M; Charsizadeh A; Hezaveh SJH; Matini AH; Ahsaniarani AH; Fakhrehi M; Mirhendi H
    J Clin Lab Anal; 2023 Apr; 37(8):e24895. PubMed ID: 37183276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective study of mucormycosis in north India: experience from a tertiary care hospital.
    Bala K; Chander J; Handa U; Punia RS; Attri AK
    Med Mycol; 2015 Apr; 53(3):248-57. PubMed ID: 25587084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.